CStone Pharmaceuticals
Bio-pharmaceutical company.
Market cap
$694m
Enterprise value
$652m
Share price
HKD4.27 2616.HK
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| N/A | $285m Valuation: $1.5b | IPO | |
| Total Funding | 000k | ||
GIC(exited)
YunFeng Capital(exited)
Taikang Life Insurance(exited)
Sequoia(exited)
6 Dimensions Capital(exited)
CITIC PE(exited)
ARCH Venture Partners(exited)
Boyu Capital(exited)
King Star Capital(exited)
Hillhouse Capital(exited)
Oriza Seed Capital(exited)
WuXi Healthcare Ventures(exited)
HongShan(exited)
Terra Magnum Capital Partners(exited)
| CNY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (77 %) | 98 % | (4 %) | (12 %) | (41 %) | 160 % | (19 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (751 %) | (164 %) | (103 %) | (8 %) | (98 %) | (8 %) | (5 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (788 %) | (188 %) | (79 %) | (22 %) | (109 %) | 69 % | (9 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 535 % | 128 % | 114 % | 33 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.